The purpose of this research study is to learn from YMSM about their perceptions of two phone apps designed to increase HIV testing, PrEP uptake, and other prevention strategies. We also want to learn about whether the apps encourage behavior change, as they are designed to do.

Collect essential data from children, adolescents, and young adults with pediatric onset rheumatic diseases and evaluate safety of therapeutic agents

To evaluate the safety and efficacy of a device removing lipids from the blood using an apheresis device in treating primary FSGS

We want to see how different approaches to group mentoring will impact postdoctoral fellows and assistant professors in both their personal and professional lives. This study will include 9 months of group meetings.

Have you been diagnosed with pancreatic cancer? If so, you may be able to take part in a research study looking at the efficacy of neoadjuvant FOLFIRINOX in subjects with non-metastatic pancreatic cancer.

If you have been treated with ANCA vasculitis and you are now in remission, you may be able to participate in a study to test if a specific blood test can help your doctor decide if you need maintenance therapy.

This study consists of two online surveys and one laboratory visit on the UNC campus. Plus, a subset of participants will be randomized to make small shifts in their daily behaviors for 35 consecutive days and all participants will complete brief nightly surveys during that 35-day phase. Some participants will also watch a short, 10 minute video.

Have you been diagnosed with multiple myeloma or high-risk smoldering multiple myeloma? If so, you may be able to take part in a research study looking at how drugs used to treat multiple myeloma work.

Do you have Neuroblastoma or Osteosarcoma that has either come back or did not get better with your last treatment? If so, you may be able to take part in a study that will modify your own immune cells to see if it may treat your cancer.

Have you been diagnosed with B-Cell Lymphoma? Are you looking for options to treat your cancer? If so, you may be able to take part in a research study looking at the safety of giving a new drug called iC9-CAR19 with Rimiducid.